Publication

Byline

Location

US Patent Issued to The Regents of the University of California, UNITED STATES GOVERNMENT REPRESENTED BY THE DEPARTMENT OF THE VETERANS AFFAIRS on Sept. 15 for "Combination immunotherapy" (California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,466, issued on Sept. 15, was assigned to The Regents of the University of California (Oakland, Calif.) and UNITED STATES GOVERNMENT REPRESE... और पढ़ें


US Patent Issued to TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH on Sept. 15 for "Polypeptide derivative having dual receptor agonistic action and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,467, issued on Sept. 15, was assigned to TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH Co. LTD. (Tianjin, China). "Polypeptide derivative h... और पढ़ें


US Patent Issued to FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON-INSTITUT DE RECERCA on Sept. 15 for "Cell-penetrating peptides" (Spanish Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,468, issued on Sept. 15, was assigned to FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON-INSTITUT DE RECERCA (Barcelona, Spain). "Cell-penetr... और पढ़ें


US Patent Issued to Regeneron Pharmaceuticals on Sept. 15 for "MAGE-A4 T cell receptors and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,469, issued on Sept. 15, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "MAGE-A4 T cell receptors and methods of use th... और पढ़ें


US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on Sept. 15 for "Engineered t cell receptors and methods of use" (Texas Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,470, issued on Sept. 15, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas). "Engineered t cell receptors an... और पढ़ें


US Patent Issued to iCell Gene Therapeutics on Sept. 15 for "Chimeric antigen receptors (CARs) targeting hematologic malignancies, compositions and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,471, issued on Sept. 15, was assigned to iCell Gene Therapeutics Inc. (Stony Brook, N.Y.). "Chimeric antigen receptors (CARs) targeting he... और पढ़ें


US Patent Issued to UNIVERSITAT STUTTGART on Sept. 15 for "TNFR2 agonists with improved stability" (German Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,472, issued on Sept. 15, was assigned to UNIVERSITAT STUTTGART (Stuttgart, Germany). "TNFR2 agonists with improved stability" was invented... और पढ़ें


US Patent Issued to Annexon on Sept. 15 for "Method of treating a blood disorder associated with C1q-mediated activation of the classical complement pathway by administering an anti-C1q antibody" (California Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,473, issued on Sept. 15, was assigned to Annexon Inc. (Brisbane, Calif.). "Method of treating a blood disorder associated with C1q-mediate... और पढ़ें


US Patent Issued to AFFILIATED HOSPITAL OF NANTONG UNIVERSITY on Sept. 15 for "Monoclonal antibody inhibiting SMIM15 and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,474, issued on Sept. 15, was assigned to AFFILIATED HOSPITAL OF NANTONG UNIVERSITY (Nantong, China). "Monoclonal antibody inhibiting SMIM1... और पढ़ें


US Patent Issued to LUDWIG INSTITUTE FOR CANCER RESEARCH, CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS on Sept. 15 for "Humanized and variant TGF-Beta3 specific antibodies and methods and uses thereof" (American, Swiss Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,475, issued on Sept. 15, was assigned to LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (Zurich) and CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS (L... और पढ़ें